
CAS 1396640-59-7 | Rezafungin
CAS:1396640-59-7
MF:C63H85N8O17
MW:1226.41
EINECS:
MDL No.:MFCD34593622
Rezafungin (formerly CD101) is a novel, next-generation echinocandin antifungal agent. It is distinguished by its long half-life, allowing for once-weekly dosing, which is a significant advancement over older echinocandins (like Caspofungin or Micafungin) that require daily infusions.
Application:
Rezafungin, also known as Rezzayo, is an echinocandin antifungal drug primarily used to treat candidemia and invasive candidiasis.
| Application Area | Description |
|---|---|
| Invasive Candidiasis | Treatment: Currently under regulatory review (Phase 3 completed) for the treatment of candidemia and invasive candidiasis.Prophylaxis: Investigated for preventing invasive fungal infections in high-risk patients (e.g., those undergoing hematopoietic stem cell transplantation or in ICUs). |
| Vulvovaginal Candidiasis | Recurrent Infections: reduction in the incidence of recurrent vulvovaginal candidiasis (RVVC) in women. |
| Antifungal Spectrum | Active against a broad range of Candida species, including strains resistant to fluconazole, and Aspergillus species. |
Related Intermediate Chemicals
Rezafungin is a semi-synthetic lipopeptide. Its structure is derived from the echinocandin B nucleus (or pneumocandin B0) via chemical modification. The key structural modification that gives Rezafungin its long half-life is the addition of a hydroxyoctanoyl side chain at the N-terminus.
| Intermediate Name | CAS Number | Role in Synthesis |
|---|---|---|
| Echinocandin B Nucleus | 104987-12-4 | The main cyclic hexapeptide structure. It is obtained by deacylation of natural Echinocandin B. |
| Pneumocandin B0 | 135575-42-7 | A natural product often used as an alternative starting material or reference standard in echinocandin synthesis. |
| 6-Bromohexanoic acid | 4224-70-8 | A main building block used in the synthesis of the lipid side chain. |
| (S)-3-Hydroxy-4-phenylbutyric acid | 80126-55-0 | A chiral intermediate used in the synthesis of the modified amino acid side chains (specifically for the hydroxylation pattern). |
| 4-((tert-Butoxycarbonyl)amino)-4-oxobutanoic acid | 34404-30-3 | A protected amino acid derivative used in peptide coupling steps. |
Summary of the Synthetic Route
The synthesis of Rezafungin is a complex semi-synthetic process:
Core Isolation: Start with the fermentation product Echinocandin B or Pneumocandin B0.
Deacylation: Remove the native fatty acid side chain to obtain the Echinocandin B Nucleus.
Side Chain Synthesis: Chemically synthesize the specific lipid side chain (a hydroxyoctanoyl derivative) that provides the pharmacokinetic advantages.
Acylation: Couple the synthetic lipid side chain to the free amino group of the cyclic hexapeptide nucleus.
Purification: Isolate the final product via chromatography.
Synonyms:
Rezafungin
1396640-59-7
SP-3025
2-[[(3S,6S,9S,11R,15S,18S,20R,21R,24S,25S,26S)-6-[(1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl]-11,20,25-trihydroxy-3,15-bis[(1R)-1-hydroxyethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-18-[[4-[4-(4-pentoxyphenyl)phenyl]benzoyl]amino]-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-21-yl]oxy]ethyl-trimethylazanium
Hot Tags: CAS 1396640-59-7 | Rezafungin, China CAS 1396640-59-7 | Rezafungin manufacturers, suppliers, api robotic process automation api integration, api business intelligence api integration, api openid connect integration, api on premises solutions, Atovaquone, api data retrieval

